CELEX: 62019TA0104
Language: en
Date: 2020-06-25 00:00:00
Title: Case T-104/19: Judgment of the General Court of 25 June 2020 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM) (EU trade mark — Revocation proceedings — EU word mark JUVÉDERM — Genuine use of the mark — Use in connection with the goods in respect of which the mark was registered — Use in the form in which the mark was registered — Use with the proprietor’s consent — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))

10.8.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 262/21
            
         
      Judgment of the General Court of 25 June 2020 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)
      (Case T-104/19) (1)
      
      (EU trade mark - Revocation proceedings - EU word mark JUVÉDERM - Genuine use of the mark - Use in connection with the goods in respect of which the mark was registered - Use in the form in which the mark was registered - Use with the proprietor’s consent - Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
      (2020/C 262/28)
      Language of the case: English
      
         Parties
      
      
         Applicant: Dermavita Co. Ltd (Beirut, Lebanon) (represented by: G. Paricheva, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: K. Zajfert, J. Crespo Carrillo, H. O’Neill and V. Ruzek, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Allergan Holdings France (Courbevoie, France) (represented by: J. Day, Solicitor, and T. de Haan, lawyer)
      
         Re:
      
      Action brought against the decision of the Fourth Board of Appeal of EUIPO of 19 December 2018 (Case R 2630/2017-4), relating to revocation proceedings between Dermavita and Allergan Holdings France.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Dermavita Co. Ltd to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO);
               
            
                  3.
               
               
                  Orders Allergan Holdings France to bear its own costs.
               
            
         (1)  OJ C 139, 15.4.2019.